Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Early tumorigenesis is associated with the engagement of the DNA-damage checkpoint response (DDR). Cell proliferation and transformation induced by oncogene activation are restrained by cellular senescence. It is unclear whether DDR activation and oncogene-induced senescence (OIS) are causally linked. Here we show that senescence, triggered by the expression of an activated oncogene (H-RasV12) in normal human cells, is a consequence of the activation of a robust DDR. Experimental inactivation of DDR abrogates OIS and promotes cell transformation. DDR and OIS are established after a hyper-replicative phase occurring immediately after oncogene expression. Senescent cells arrest with partly replicated DNA and with DNA replication origins having fired multiple times. In vivo DNA labelling and molecular DNA combing reveal that oncogene activation leads to augmented numbers of active replicons and to alterations in DNA replication fork progression. We also show that oncogene expression does not trigger a DDR in the absence of DNA replication. Last, we show that oncogene activation is associated with DDR activation in a mouse model in vivo. We propose that OIS results from the enforcement of a DDR triggered by oncogene-induced DNA hyper-replication.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inhibition of DDR signalling kinases (ATM, ATR, CHK1 and CHK2) allows senescent cells to re-enter the cell cycle7,24,25”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [7]
In the citing paper
“Oncogene activation is a powerful inducer of cellular senescence. Oncogene expression triggers an initial hyperproliferative phase that is intrinsically associated with altered DNA replication, which eventually engages DDR pathways and causes senescence7,8,39”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [7]
In the citing paper
“In normal cells, however, oncogenic RAS causes genotoxic stress and senescence [ 57 , 58 ], inducing a SASP and thereby conferring complex cell-nonautonomous oncogenic activities.”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [57]
In the citing paper
“Indeed, most oncogenes that have been studied in the literature cause replication stress by increasing origin firing and triggering DNA damage [12, 29]”
From The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia (2017) · cites this paper as [12]
In the citing paper
“It has been shown that one mechanism for the link between the initial mitotic reaction and senescence induction is the S-phase-associated DDR: The oncogenic stress drives increased DNA replication origins, leading to accumulation of incomplete replication intermediates, resulting in DNA damage and activation of the DDR kinases (ATM, ATR, CHK2, and CHK1) (Bartkova et al. 2006; Di Micco et al. 2006;”
From Cellular senescence and its effector programs (2014) · cites this paper as Di Micco et al. 2006
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Oncogenic activity of Cdc6 through repression of the INK4/ARF locus
Gonzalez, S., Klatt, P., Delgado, S., Conde, E., Lopez-Rios, F., Sanchez-Cespedes, M., Mendez, J., Antequera, F., & Serrano, M. (2006) · Nature · doi:10.1038/nature04585 · Cited by 186
RetractedA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Cited by
Items 801–900 of 1,011
Chromosome instability and deregulated proliferation: an unavoidable duo
Coschi, C. H., & Dick, F. A. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0910-4 · Cited by 42
Hubáčková, S., Krejčíková, K., Bártek, J., & Hodný, Z. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.316869 · Cited by 46
Qiu, Z., Fa, P., Liu, T., Prasad, C. B., Ma, S., Hong, Z., Chan, E. R., Wang, H., Li, Z., He, K., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0057 · Cited by 43
Cellular senescence in liver fibrosis: Implications for age-related chronic liver diseases
Udomsinprasert, W., Sobhonslidsuk, A., Jittikoon, J., Honsawek, S., & Chaikledkaew, U. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1992385 · Cited by 40
Chen, L., Fu, L., Kong, X., Xu, J., Wang, Z., Ma, X., Akiyama, Y., Chen, Y., & Fang, J. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.808 · Cited by 39
“Because senescence, initiated by oncogene activation, telomere dysfunction, or other stimulus, is frequently associated with DNA damage (Di Micco et al, 2006), our results, therefore, strongly suggest that JMJD2B silencing-induced senescence could result from cellular response to DNA damage.”
BackgroundMortusewicz, O., Herr, P., & Helleday, T. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.20 · Cited by 41
Cyclin D1 Integrates Estrogen-Mediated DNA Damage Repair Signaling
Li, Z., Chen, K., Jiao, X., Wang, C., Willmarth, N. E., Casimiro, M. C., Li, W., Ju, X., Kim, S. H., Lisanti, M. P., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3137 · Cited by 43
“Activated oncogenes, including c-Myc, Ras, Mos, CDC25, E2F1, cyclin D1 and cyclin E (3-6), induce double-stranded DNA breaks (DSB) and the DDR.”
BackgroundATR inhibition rewires cellular signaling networks induced by replication stress
Wagner, S., Oehler, H., Voigt, A., Dalic, D., Freiwald, A., Serve, H. L., & Beli, P. (2015) · PROTEOMICS · doi:10.1002/pmic.201500172 · Cited by 43
“Overexpression or constitutive activation of oncogenes such as Cyclin E, Myc, and HRAS that frequently occurs in cancer has been shown to result in DNA replication stress [2, 18].”
BackgroundFibroblast activation and senescence in oral cancer
Prime, S. S., Cirillo, N., Hassona, Y. M., Lambert, D., Paterson, I. C., Mellone, M., Thomas, G. J., James, E. N., & Parkinson, E. K. (2016) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12456 · Cited by 43
Ciliary abnormalities in senescent human fibroblasts impair proliferative capacity
Breslin, L., Prosser, S. L., Cuffe, S., & Morrison, C. G. (2014) · Cell Cycle · doi:10.4161/15384101.2015.945868 · Cited by 39
“Senescence can arise through persistent DNA damage signaling, notably at telomeric sequences that can become exposed after multiple divisions(4-6) or through a response to strong mitogenic signaling induced by oncogenes.(7,8) Senescenceinduced changes include the increased expression of senescenceassociated ß-galactos…”
BackgroundMetabolic alterations accompanying oncogene-induced senescence
Aird, K. M., & Zhang, R. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.963481 · Cited by 39
“For instance, loss of p53 can suppress OIS in some contexts.(10,31,32) p53 is known to transcriptionally repress glucose transporters (GLUT-1, GLUT-3, GLUT-4) and a number of glycolytic enzymes.”
BackgroundSwitching on p53: an essential role for protein phosphorylation?
Loughery, J., & Meek, D. W. (2013) · Biodiscovery · doi:10.7750/biodiscovery.2013.8.1 · Cited by 49
Oncogene-Induced Replication Stress Drives Genome Instability and Tumorigenesis
Sarni, D., & Kerem, B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071339 · Cited by 41
“This DDR activation could lead to proliferation arrest either in the form of senescence or apoptosis, forming a tumorigenic barrier [13,14].”
BackgroundCellular senescence signaling in cancer: A novel therapeutic target to combat human malignancies
Fakhri, S., Moradi, S. Z., DeLiberto, L. K., & Bishayee, A. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114989 · Cited by 42
Senescence of Tumor Cells in Anticancer Therapy—Beneficial and Detrimental Effects
Piskorz, W. M., & Cechowska‐Pasko, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911082 · Cited by 44
Sherman, M. Y., Le, M., Stampfer, M. R., Gabai, V. L., & Yaglom, J. A. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00736.x · Cited by 41
“Furthermore, inhibition or knocking down of the DDR mediators prevented OIS and facilitated transformation of melanocytes (Di Micco et al., 2006; Mallette et al., 2007).”
BackgroundDNA damage and cellular differentiation: More questions than responses
Simonatto, M., Latella, L., & Puri, P. L. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21275 · Cited by 39
Controversial aspects of oncogene-induced senescence
Bianchi-Smiraglia, A., & Nikiforov, M. A. (2012) · Cell Cycle · doi:10.4161/cc.22589 · Cited by 38
“For example, several reports demonstrated that depletion of p53 allows the proliferation of HRAS-expressing normal human fibroblasts.(2,23,50-52) At the same time, HRAS caused senescence independently of p53 in primary human esophageal keratinocytes.”
BackgroundWidespread activation of the DNA damage response in human pancreatic intraepithelial neoplasia
Koorstra, J.-B. M., Hong, S., Shi, C., Meeker, A. K., Ryu, J. K., Offerhaus, G. J. A., Goggins, M., Hruban, R. H., & Maitra, A. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.114 · Cited by 44
Myc, Cdk2 and cellular senescence: Old players, new game
Campaner, S., Doni, M., Verrecchia, A., Fagà, G., Bianchi, L., & Amati, B. B. (2010) · Cell Cycle · doi:10.4161/cc.9.18.13049 · Cited by 44
Advances in melanoma senescence and potential clinical application
Giuliano, S., Ohanna, M., Ballotti, R., & Bertolotto, C. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00820.x · Cited by 47
“Further, MYC, MITF, TBX2, DEK and SYK have been associated with the control of genomic stability (Davis et al., 2008; Felsher and Bishop, 1999; Giuliano et al., 2010; Zyss et al., 2005), suggesting additional levels of senescence control that are not mentioned in Figure 2.”
BackgroundIntroduction to Molecular Combing: Genomics, DNA Replication, and Cancer
Herrick, J., & Bensimon, A. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-815-7_5 · Cited by 39
Self-citationRimmelé, P., Komatsu, J., Hupé, P., Roulin, C., Barillot, E., Dutreix, M., Conseiller, E., Bensimon, A., Moreau-Gachelin, F., & Guillouf, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4691 · Cited by 38
“Spi-1 does not provoke DNA strand breaks but enhances genomic mutability Altered DNA replication leads to genomic instability in yeast (23) and human precancerous cells (2, 3, 5, 7).”
BackgroundSelf-citationSenescence and pre-malignancy: How do tumors progress?
Saab, R. H. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.013 · Cited by 42
From Development to Aging: The Path to Cellular Senescence
Sacco, A., Belloni, L., & Latella, L. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8071 · Cited by 41
“Oncogene expression might induce senescence, referred as oncogene-induced senescence (OIS), which is associated with DNA damage or hyper-replication (40).”
BackgroundKu, A. A., Hu, H., Zhao, X., Shah, K. N., Kongara, S., Wu, D., McCormick, F. P., Balmain, A., & Bandyopadhyay, S. (2020) · Nature Communications · doi:10.1038/s41467-020-16078-y · Cited by 40
Old disease, new culprit: Tumor stem cells in cancer
Lee, J. T., & Herlyn, M. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21252 · Cited by 43
“…another form of senescence exists: oncogene-induced senescence (OIS); this latter biological occurrence prevents tumorigenesis by inhibiting cell division after oncogenic insult via activation of the DNA damage repair response (Bartkova et al., 2006; Di Micco et al., 2006; Mallette et al., 2007).”
BackgroundSenescence; an endogenous anticancer mechanism
Vargas, J. E., Feltes, B. C., Poloni, J. D. F., Lenz, G., & Bonatto, D. (2012) · Frontiers in bioscience · doi:10.2741/4074 · Cited by 43
“Oncogenic stress mediated by Ras has been shown to induce genome instability after a single round of DNA replication (21), while CDC6 overexpression is sufficient to induce DDR activation and senescence (22).”
BackgroundNair, R. R., Bagheri, M., & Saini, D. K. (2015) · Journal of Cell Science · doi:10.1242/jcs.159517 · Cited by 38
Modulation of the DNA-damage response to HZE particles by shielding
MUKHERJEE, B., Camacho, C. V., Tomimatsu, N., MILLER, J. A., & Burma, S. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.06.016 · Cited by 40
Rai, P. (2012) · Small GTPases · doi:10.4161/sgtp.19556 · Cited by 38
Insights into the role of senescence in tumor dormancy: mechanisms and applications
DeLuca, V. J., & Saleh, T. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10082-6 · Cited by 41
“Following oncogene activation, cells may become hyper-proliferative, and over-replication of DNA can lead to replication fork alterations that subsequently cause senescence-enforcing DNA damage [30, 31].”
BackgroundNeural cell state shifts and fate loss in ageing and age-related diseases
Traxler, L., Lucciola, R., Herdy, J. R., Jones, J. R., Mertens, J., & Gage, F. H. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00815-0 · Cited by 43
Senescence in cancer: Advances in detection and treatment modalities
Billimoria, R., & Bhatt, P. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115739 · Cited by 38
Wang, P., Konja, D., Singh, S., Zhang, B., & Wang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25041978 · Cited by 42
Peterson, T. A., Park, D., & Kann, M. G. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-s3-s5 · Cited by 40
“This domain position corresponds to position 12 of both the human HRAS and KRAS genes, from which many mutations have been implicated in diseases such as Costello syndrome [43-46] and Congenital myopathy [47,48] and have also been found to be mutated frequently in somatic tumor samples from patients with follicular th…”
BackgroundFolate levels modulate oncogene‐induced replication stress and tumorigenicity
Lamm, N., Maoz, K., Bester, A. C., Im, M. M., Shewach, D. S., Karni, R., & Kerem, B. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404824 · Cited by 40
Yang, Y., Yin, R., Wu, R., Ramirez, C. N., Sargsyan, D., Li, S. N., Wang, L., Cheng, D., Wang, C., Hudlikar, R. R., et al. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23046 · Cited by 37
A P53-Independent DNA Damage Response Suppresses Oncogenic Proliferation and Genome Instability
Fagan‐Solis, K. D., Simpson, D. A., Kumar, R. J., Martelotto, L. G., Mose, L. E., Rashid, N. U., Ho, A. Y., Powell, S. N., Wen, Y., Parker, J. S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.020 · Cited by 40
Fumasoni, M., & Murray, A. W. (2020) · eLife · doi:10.7554/elife.51963 · Cited by 40
Venkatesh, R., Ramaiah, M. J., Gaikwad, H. K., Janardhan, S., Bantu, R., Nagarapu, L., Sastry, G. N., Ganesh, R. A., & Bhadra, M. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.02.057 · Cited by 37
Titration of RAS alters senescent state and influences tumour initiation
Chan, A. S. L., Zhu, H., Narita, M., Cassidy, L. D., Young, A. R. J., Bermejo‐Rodríguez, C., Janowska, A. T., Chen, H., Gough, S., Oshimori, N., et al. (2024) · Nature · doi:10.1038/s41586-024-07797-z · Cited by 38
Disruptive chemicals, senescence and immortality
Carnero, A., Blanco-Aparicio, C., Kondoh, H., Lleonart, M. E., Martinez-Leal, J. F., Mondello, C., Scovassi, A. I., Bisson, W. H., Amedei, A., Roy, R., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv029 · Cited by 29
Hsu, C.-C., Lee, Y., Yeh, S.-H., Chen, C.-H., Wu, C., Wang, T., Chen, Y.-N., Hung, L., Liu, Y.-W., Chen, H.-K., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.335331 · Cited by 39
DNA damage response in adult stem cells
Insinga, A., Cicalese, A., & Pelicci, P. G. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.12.005 · Cited by 41
Self-citationInterplay between genetic and epigenetic factors governs common fragile site instability in cancer
Ozeri-Galai, E., Sinai, M. I., Bester, A. C., & Kerem, B. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1719-8 · Cited by 39
“Recent studies, however, have shown that activation of oncogenes leads to perturbed DNA replication, resulting in hyper-replication, slow replication fork progression and activation of dormant origins of replication [29, 30, 98, 99].”
BackgroundLimited nucleotide pools restrict Epstein–Barr virus-mediated B-cell immortalization
Hafez, A. Y., Messinger, J. E., McFadden, K., Fenyőfalvi, G., Shepard, C., Lenzi, G. M., Kim, B., & Luftig, M. A. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.46 · Cited by 36
p53 regulated senescence mechanism and role of its modulators in age-related disorders
Pawge, G., & Khatik, G. L. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114651 · Cited by 44
McGrail, D. J., Pilie, P. G., Dai, H., Lam, T., Liang, Y., Voorwerk, L., Kok, M., Zhang, X. H.-F., Rosen, J. M., Heimberger, A. B., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe6201 · Cited by 36
Replication Stress: A Lifetime of Epigenetic Change
Khurana, S., & Oberdoerffer, P. (2015) · Genes · doi:10.3390/genes6030858 · Cited by 40
“Oncogene activation results in an initial phase of hyper-proliferation, which triggers excessive DNA replication, multiple origin activation and, eventually, replication stress-associated DDR activation [34,35].”
BackgroundTurning anti-ageing genes against cancer
Longo, V. D., Lieber, M. R., & Vijg, J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2526 · Cited by 43
At the stem of youth and health
Beltrami, A. P., Cesselli, D., & Beltrami, C. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.10.005 · Cited by 40
“With respect to this latter, its importance in preventing oncogenesis is supported by the observation that DDRdeficient cells do not arrest proliferation following oncogene activation, ending up in transformation and tumor formation (Di Micco et al., 2006).”
BackgroundInfluentialEctopic expression of cancer/testis antigen SSX2 induces DNA damage and promotes genomic instability
Greve, K. B. V., Lindgreen, J., Terp, M. G., Pedersen, C. B., Schmidt, S., Mollenhauer, J., Kristensen, S. B., Andersen, R. S., Relster, M. M., Ditzel, H. J., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.09.001 · Cited by 39
Chondrogianni, N., Trougakos, I. P., Kletsas, D., Chen, Q. M., & Gonos, E. S. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00425.x · Cited by 37
“Since it was shown that oncogene induced senescence involves activation of p53 via the DNA damage response (Di Micco et al. , 2006), we have checked for evidence of a DNA damage response in our experimental model.”
Frum, R. A., Singh, S. K., Vaughan, C. A., Mukhopadhyay, N. D., Grossman, S. R., Windle, B. E., Deb, S., & Deb, S. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt944 · Cited by 37
“Oncogenic Ras is known to induce a DNA damage repair response (3); Raf-1 induces cell cycle arrest and senescence (4); and MYC is known to trigger DNA damage and checkpoint response (5,6).”
O’Hara, S. P., Splinter, P. L., Trussoni, C. E., Pisarello, M. J. L., Loarca, L., Splinter, N. S., Schutte, B. F., & LaRusso, N. F. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.777409 · Cited by 36
“Indeed, it has been shown that aberrant expression of oncogenic RAS promotes cultured cell senescence through DNA damage induced during the initial period of hyperproliferation and the induction of the DDR (30).”
BackgroundInfluentialProteomic analysis of p16ink4a‐binding proteins
Souza‐Rodrígues, E., Estanyol, J. M., Friedrich‐Heineken, E., Moreno, E. M. O., Vera, J., Canela-Canela, N., Brun, S., Agell, N., Hübscher, U., Bachs, O., et al. (2007) · PROTEOMICS · doi:10.1002/pmic.200700133 · Cited by 41
Quantitative model of cell cycle arrest and cellular senescence in primary human fibroblasts
Schäuble, S., Klement, K., Marthandan, S., Münch, S., Heiland, I., Schuster, S., Hemmerich, P., & Diekmann, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042150 · Cited by 35
“age sites, in this case at collapsed replication forks [35,42–44].”
BackgroundMazzucco, A. E., Smogorzewska, A., Kang, C., Luo, J., Schlabach, M. R., Xu, Q., Patel, R., & Elledge, S. J. (2017) · Genes & Development · doi:10.1101/gad.304857.117 · Cited by 35
Borlon, C., Debacq-Chainiaux, F., Hinrichs, C., Scharffetter-Kochanek, K., Toussaint, O., & Wlaschek, M. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.04.009 · Cited by 35
The Effects of Replication Stress on S Phase Histone Management and Epigenetic Memory
Šviković, S., & Sale, J. E. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.11.011 · Cited by 36
SFPQ Depletion Is Synthetically Lethal with BRAFV600E in Colorectal Cancer Cells
Klotz‐Noack, K., Klinger, B., Rivera, M., Bublitz, N., Uhlitz, F., Riemer, P., Lüthen, M., Sell, T., Kasack, K., Gastl, B., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108184 · Cited by 41
Autophagy and senescence in cancer therapy
Patel, N. H., Bloukh, S., Alwohosh, E., Alhesa, A., Saleh, T., & Gewirtz, D. A. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.002 · Cited by 42
Celis, J. E., Moreira, J. M. A., Gromova, I., Cabezón, T., Gromov, P., Shen, T., Wielenga, V. T., & Rank, F. E. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.02.005 · Cited by 37
Zuazua‐Villar, P., Rodríguez, R., Gagou, M. E., Eyers, P. A., & Meuth, M. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.231 · Cited by 39
The Role of Hypoxia Inducible Factor-1 Alpha in Bypassing Oncogene-Induced Senescence
Kilic Eren, M., & Tabor, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101064 · Cited by 36
“Recent studies have shown the involvement of DNA damage signaling through ATM/ATR kinases as a crucial mediator of oncogene induced senescence [8,9,11,12].”
BackgroundCD20-Targeting Immunotherapy Promotes Cellular Senescence in B-Cell Lymphoma
Däbritz, J. H. M., Yu, Y., Milanovic, M., Schönlein, M., Rosenfeldt, M. T., Dörr, J. R., Kaufmann, A. M., Dörken, B., & Schmitt, C. A. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0627 · Cited by 37
“Vertical marks indicate the positions of bead clouds corresponding to two major SASP cytokines, i.e., IL6 (red) and IL8 (blue) compared with untreated controls (hatched lines) for different ADR concentrations without RTXCL (top) or with RTXCL (bottom).”
BackgroundInfluentialA Tale of Ice and Fire: The Dual Role for 17β-Estradiol in Balancing DNA Damage and Genome Integrity
Pescatori, S., Berardinelli, F., Albanesi, J., Ascenzi, P., Marino, M., Antoccia, A., di Masi, A., & Acconcia, F. (2021) · Cancers · doi:10.3390/cancers13071583 · Cited by 37
Aging Triggers Mitochondrial Dysfunction in Mice
Rosa, F. L. L., de Souza, I. I. A., Monnerat, G., de Carvalho, A. C. C., & Maciel, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310591 · Cited by 35
“An increase in reactive oxygen species (ROS) production due to mitochondrial dysfunction is characteristic in several models of cellular senescence, including stress-induced senescence [8], replicative senescence [9], oncogene-induced senescence [10], and senescence triggered by genetic telomere uncapping [11].”
BackgroundPassananti, C., & Fanciulli, M. (2007) · Cell Division · doi:10.1186/1747-1028-2-21 · Cited by 34
“Based on these observations, it is reasonable to speculate that Che-1 may be a component of the anticancer barrier that protects cells from DNA damage or oncogenic stress [14,15] by inducing cellular senescence [16,17].”
BackgroundCrosstalk between P53 and DNA damage response in ageing
Mohammadzadeh, A., Mirza‐Aghazadeh‐Attari, M., Hallaj, S., Saei, A. A., Alivand, M. R., Valizadeh, A., Yousefi, B., & Majidinia, M. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.05.004 · Cited by 37
Zebrafish Cancer Predisposition Models
Kobar, K., Collett, K., Prykhozhij, S. V., & Berman, J. N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.660069 · Cited by 39
Lee, A. Y.-L., Liu, E., & Wu, X. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705486200 · Cited by 35
Hohenauer, T., Berking, C., Schmidt, A., Haferkamp, S., Senft, D., Kammerbauer, C., Fraschka, S. A. K., Graf, S. A., Irmler, M., Beckers, J., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201862 · Cited by 40
“DNA double-strand breaks due to DNA replication stress have been implicated in oncogene-induced senescence (Bartkova et al, 2006; Di Micco et al, 2006) and active RAS/RAF signalling can lead to tumourigenesis when p53 is inactivated (Dankort et al, 2007; Patton et al, 2005; Serrano et al, 1997; Yu…”
Early S-phase cell hypersensitivity to heat stress
Petrova, N. V., Velichko, A. K., Razin, S. V., & Kantidze, O. L. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1127477 · Cited by 34
Dissecting cellular senescence and SASP in Drosophila
Ito, T., & Igaki, T. (2016) · Inflammation and Regeneration · doi:10.1186/s41232-016-0031-4 · Cited by 36
“Studies in mammalian systems have indicated that Ras activation elicits DNA damage mainly through DNA hyper-replication [3, 10] and production of reactive oxygen species (ROS) [13, 51–55].”
Mitotic DNA Synthesis Is Differentially Regulated between Cancer and Noncancerous Cells
Graber-Feesl, C. L., Pederson, K. D., Aney, K. J., & Shima, N. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0057 · Cited by 35
“Studies have demonstrated that overexpression of certain oncogenes in cultured human cells induces replication stress by disturbing the normal kinetics of DNA replication, altering the usage of replication origins and fork speed (3, 4).”
BackgroundNiihori, T., Aoki, Y., Okamoto, N., Kurosawa, K., Ohashi, H., Mizuno, S., Kawame, H., Inazawa, J., Ohura, T., Arai, H., et al. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.85 · Cited by 34
“31 which protects cells from proliferating in the presence of oncogene-induced damage”
BackgroundHelleday, T. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.044 · Cited by 35
Retinoblastoma Loss Modulates DNA Damage Response Favoring Tumor Progression
Seoane, M., Iglesias, P., González, T., Domínguez, F., Fraga, M., Aliste, C., Forteza, J., & Costoya, J. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003632 · Cited by 37
“Although the mechanisms that generate DNA damage put in place by different oncogenic events are unclear presently, Ras activation induces not only ROSinduced DNA damage but also re-replication, an event known to cause DDR activation [21].”
BackgroundYang, M., Xiang, H., & Luo, G. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01619 · Cited by 33
The role of cyclin D1 in response to long-term exposure to ionizing radiation
Shimura, T., Fukumoto, M., & Kunugita, N. (2013) · Cell Cycle · doi:10.4161/cc.25746 · Cited by 38
Targeting LINC00673 expression triggers cellular senescence in lung cancer
Roth, A., Boulay, K., Groß, M., Polycarpou‐Schwarz, M., Mallette, F. A., Regnier, M., Bida, O., Ginsberg, D., Warth, A., Schnabel, P. A., et al. (2018) · RNA Biology · doi:10.1080/15476286.2018.1553481 · Cited by 36
Gong, Z., Li, Q., Li, J., Xie, J., & Wang, W. T. (2022) · Translational Cancer Research · doi:10.21037/tcr-21-1554 · Cited by 35
“Cellular senescence was enriched in the network and has been shown to restrain the cell proliferation and transformation induced by oncogene activation (31).”
BackgroundGene regulation and tumor suppression by the bromodomain-containing protein BRD7
Mantovani, F., Drost, J., Voorhoeve, P. M., Sal, G. D., & Agami, R. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12309 · Cited by 34
“Specifically, the initial hyperreplication phase fostered by oncogene activity leads to replication stress, which eventually drives cells into senescence.(4,5)”
BackgroundRole of DNA repair machinery and p53 in the testicular germ cell cancer: a review
Romano, F. J., Rossetti, S., Conteduca, V., Schepisi, G., Cavaliere, C., Franco, R. D., Mantia, E. L., Castaldo, L., Nocerino, F., Ametrano, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13063 · Cited by 35
Mechanisms of oncogene-induced genomic instability
Graziano, S., & Gonzalo, S. (2016) · Biophysical Chemistry · doi:10.1016/j.bpc.2016.11.008 · Cited by 37
“In fact, cells expressing oncogenic Ras (HRasG12V) but unable to activate DDR due to depletion of either Chk2 or ATM, do not enter senescence [8, 26].”
The Power Behind the Throne: Senescence and the Hallmarks of Cancer
Hoare, M., & Narita, M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050352 · Cited by 33
AATF suppresses apoptosis, promotes proliferation and is critical for Kras-driven lung cancer
Welcker, D., Jain, M., Khurshid, S., Jokić, M., Höhne, M., Schmitt, A., Frommolt, P., Niessen, C. M., Spiro, J., Persigehl, T., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0054-6 · Cited by 35
Kitajima, S., Miki, T., Takegami, Y., Kido, Y., Noda, M., Hara, E., Shamma, A., & Takahashi, C. (2010) · Oncogene · doi:10.1038/onc.2010.448 · Cited by 37
“Cellular senescence induced by oncogenic RAS has been proposed to be mediated by DNA hyper-replication and following DNA damage response (Bartkova et al., 2006; Di Micco et al., 2006); this may explain RECK depletion-induced cellular senescence.”
BackgroundSenescence is a Spi1-induced anti-proliferative mechanism in primary hematopoietic cells
Delestré, L., Cui, H., Esposito, M., Quiveron, C., Mylonas, E., Penard-Lacronique, V., Bischof, O., & Guillouf, C. (2017) · Haematologica · doi:10.3324/haematol.2016.157636 · Cited by 32
MRE11 and TREX1 control senescence by coordinating replication stress and interferon signaling
Técher, H., Gopaul, D., Heuzé, J., Bouzalmad, N., Leray, B., Vernet, A., Mettling, C., Moreaux, J., Pasero, P., & Lin, Y. (2024) · Nature Communications · doi:10.1038/s41467-024-49740-w · Cited by 37
“One of the earliest manifestations of RAS V12 -induced RS is a dramatic reduction in fork velocity 4,9,11,46 .”
Chronic social stress induces p16-mediated senescent cell accumulation in mice
Lyons, C. E., Pallais, J. P., McGonigle, S., Mansk, R. P., Collinge, C. W., Yousefzadeh, M. J., Baker, D. J., Schrank, P. R., Williams, J. W., Niedernhofer, L. J., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00743-8 · Cited by 36
“However, if p21 -induced arrest is sustained, p16 Ink4a will also become expressed, resulting in permanent cell cycle arrest. p16 Ink4a can also be directly induced by other factors, including oncogenic signaling 34,35 .”
Allday, M. J. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00212 · Cited by 33
“…proposed that the induction of apoptosis or cell cycle arrest/senescence by oncogenic stress is a general downstream manifestation of the DDR acting as a barrier to cell transformation in vitro and tumor progression in vivo (Di Micco et al., 2006; Bartek et al., 2007; Halazonetis et al., 2008).”
BackgroundInterferon alpha-inducible protein 6 regulates NRASQ61K-induced melanomagenesis and growth
Gupta, R., Forloni, M., Bisserier, M., Dogra, S. K., Yang, Q., & Wajapeyee, N. (2016) · eLife · doi:10.7554/elife.16432 · Cited by 34
Gellon, L., Kaushal, S., Cebrián, J., Lahiri, M., Mirkin, S. M., & Freudenreich, C. H. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1195 · Cited by 33
Gillispie, G. J., Sah, E., Krishnamurthy, S., Ahmidouch, M. Y., Zhang, B., & Orr, M. E. (2021) · Life · doi:10.3390/life11020153 · Cited by 34
“Evolutionarily, the ability for proliferative cells to undergo senescence in response to cell damage provided an advantage over malignancy [93,94].”
BackgroundLoss of CMTM6 promotes DNA damage-induced cellular senescence and antitumor immunity
Wang, H., Fan, Y., Chen, W., Lv, Z., Wu, S., Xuan, Y., Wang, C., Lu, Y., Guo, T., Shen, D., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2021.2011673 · Cited by 38
Chojak, R., Fares, J., Petrosyan, E., & Lesniak, M. S. (2023) · Journal of Neuro-Oncology · doi:10.1007/s11060-023-04387-3 · Cited by 35
Homeodomain‐interacting protein kinase2 in human idiopathic pulmonary fibrosis
Rícci, A., Cherubini, E., Ulivieri, A., Lavra, L., Sciacchitano, S., Scozzi, D., Mancini, R., Ciliberto, G., Bartolazzi, A., Bruno, P., et al. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24129 · Cited by 32
Metadata
- Authors
- Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., Maestro, R., Giuseppe Pelicci, P., & d’Adda di Fagagna, F.
- Affiliations
- IFOM (IT)
- European Institute of Oncology (IT)
- Centro di Riferimento Oncologico (IT)
- Institut Pasteur (FR)
- Genomic Vision (France) (FR)
- Venue
- Nature
- Published
- 2006-11
- Volume
- 444
- Issue
- 7119
- Pages
- 638-642
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2121371748
- Cited by
- 1,821
- References
- 30
- Citations by year
- 2026: 50 · 2025: 58 · 2024: 62 · 2023: 76 · 2022: 80 · 2021: 118 · 2020: 84 · 2019: 81 · 2018: 104 · 2017: 84 · 2016: 110 · 2015: 89 · 2014: 118 · 2013: 107 · 2012: 115
- FWCI
- 58.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- oncogene-induced senescence, DNA damage response, H-Ras V12, origin of replication, DNA replication fork progression, cell transformation, carcinogenesis, senescence markers, DNA combing
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Cells, Cultured, DNA Replication, Genetic Markers, Humans, Genes, ras, Cellular Senescence, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.